lorazepam has been researched along with Body Weight in 12 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aripiprazole was associated with beneficial effects on mood in patients with bipolar depression, and appears well tolerated with very small changes in mean body weight." | 5.13 | Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial. ( Bria, P; Janiri, L; Mazza, M; Pecora, RD; Squillacioti, MR, 2008) |
| " The symptoms 'loss of body weight' and 'decrease in food intake' appeared to be more sensitive in benzodiazepine withdrawal: they were dose dependently present over the whole dosage range (2." | 1.29 | Tolerance and withdrawal after chronic lorazepam treatment in rats. ( de Groot, G; Jansen van't Land, C; van der Laan, JW, 1993) |
| " Flupirtine yielded a dose-response curve with an ED50 of 3." | 1.28 | Investigations with the novel non-opioid analgesic flupirtine in regard to possible benzodiazepine-like abuse inducing potential. ( Borbe, HO; Nickel, B; Szelenyi, I, 1990) |
| "Dogs, surgically implanted with a gastric fistula, were chronically dosed with diazepam or lorazepam." | 1.27 | Physical dependence on diazepam and lorazepam in the dog. ( Cherian, S; Martin, WR; McNicholas, LF, 1983) |
| "Dogs, surgically implanted with a chronic gastric fistula, were chronically dosed with N-desmethyldiazepam (32 mg/kg/day) in four divided doses to attain N-desmethyldiazepam plasma levels comparable to those observed in dogs dependent on diazepam (60 mg/kg/day)." | 1.27 | N-desmethyldiazepam physical dependence in dogs. ( Martin, WR; McNicholas, LF; Pruitt, TA, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Waltuch, T | 1 |
| Munjal, K | 1 |
| Loo, GT | 1 |
| Lim, CA | 1 |
| Mazza, M | 1 |
| Squillacioti, MR | 1 |
| Pecora, RD | 1 |
| Janiri, L | 1 |
| Bria, P | 1 |
| Oswald, I | 2 |
| Adam, K | 2 |
| McNicholas, LF | 2 |
| Martin, WR | 2 |
| Cherian, S | 1 |
| van der Laan, JW | 1 |
| Jansen van't Land, C | 1 |
| de Groot, G | 1 |
| Siassi, I | 1 |
| Thomas, M | 1 |
| Vanov, SK | 1 |
| Laegreid, L | 1 |
| Hagberg, G | 1 |
| Lundberg, A | 1 |
| Miller, LG | 1 |
| Chesley, S | 1 |
| Galpern, WR | 1 |
| Greenblatt, DJ | 1 |
| Shader, RI | 1 |
| Crom, WR | 1 |
| Relling, MV | 1 |
| Christensen, ML | 1 |
| Rivera, GK | 1 |
| Evans, WE | 1 |
| Nickel, B | 1 |
| Borbe, HO | 1 |
| Szelenyi, I | 1 |
| Pruitt, TA | 1 |
4 trials available for lorazepam and Body Weight
| Article | Year |
|---|---|
Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Ag | 2008 |
Benzodiazepines cause small loss of body weight.
Topics: Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Body Weight; Female; Humans; Lorazepam; Male; Mid | 1980 |
Evaluation of the safety and therapeutic effects of lorazepam on long-term use.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Blood Pressure; Body Weight; Clinical Trials as Topic; Diaze | 1975 |
Can a rapidly-eliminated hypnotic cause daytime anxiety?
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Body Weight; Dreams; Female; Humans; Hyp | 1989 |
8 other studies available for lorazepam and Body Weight
| Article | Year |
|---|---|
AiRDose: Developing and Validating an Augmented Reality Smartphone Application for Weight Estimation and Dosing in Children.
Topics: Augmented Reality; Body Weight; Child; Child, Preschool; Cross-Sectional Studies; Epinephrine; Human | 2022 |
Physical dependence on diazepam and lorazepam in the dog.
Topics: Animals; Anti-Anxiety Agents; Body Weight; Diazepam; Dogs; Female; Gait; Humans; Lorazepam; Pyrazole | 1983 |
Tolerance and withdrawal after chronic lorazepam treatment in rats.
Topics: Animals; Body Weight; Drug Tolerance; Eating; Lorazepam; Male; Motor Activity; Psychomotor Performan | 1993 |
Neurodevelopment in late infancy after prenatal exposure to benzodiazepines--a prospective study.
Topics: Abnormalities, Drug-Induced; Anti-Anxiety Agents; Arousal; Body Height; Body Weight; Cephalometry; D | 1992 |
Prenatal benzodiazepine administration. II. Lorazepam exposure is associated with decreases in [35S]TBPS binding but not benzodiazepine binding.
Topics: Animals; Body Weight; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Female; Lo | 1991 |
Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrine.
Topics: Adolescent; Adult; Age Factors; Antipyrine; Body Weight; Child; Child, Preschool; Female; Humans; In | 1991 |
Investigations with the novel non-opioid analgesic flupirtine in regard to possible benzodiazepine-like abuse inducing potential.
Topics: Aminopyridines; Analgesics; Animals; Anti-Anxiety Agents; Binding, Competitive; Body Weight; Brain C | 1990 |
N-desmethyldiazepam physical dependence in dogs.
Topics: Analysis of Variance; Animals; Body Weight; Diazepam; Dogs; Drinking; Energy Intake; Female; Lorazep | 1985 |